Table 2.
Association between metabolic syndrome (MetS) diagnosis and in-hospital mortality among patients with cancer, Nationwide Inpatient Sample, 2007–2011
| Cancer type | |||
|---|---|---|---|
|
| |||
| Breast cancer AOR (95%CI) | Colorectal cancer AOR (95%CI) | Prostate cancer AOR (95%CI) | |
| MetS diagnosis | |||
| No | Ref | Ref | Ref |
| Yes | 0.31(0.20–0.46) | 0.41(0.35–0.49) | 0.28(0.16–0.49) |
| Age groups | |||
| ≧ 40 < 50 | Ref | Ref | Ref |
| ≧ 50 < 60 | 1.17(0.98–1.39) | 1.17(1.01–1.34) | 2.41(0.87–6.63) |
| ≧ 60 < 70 | 1.58(1.31–1.89) | 1.63(1.42–1.87) | 4.56(1.68–12.36) |
| ≧ 70 | 2.86(2.32–3.52) | 3.40(2.96–3.90) | 24.66(9.12–66.69) |
| Gender | |||
| Males | - | Ref | - |
| Females | - | 0.86(0.82–0.92) | - |
| Race | |||
| Whites | Ref | Ref | Ref |
| Blacks | 1.11(0.95–1.31) | 1.08(0.99–1.18) | 1.04(0.85–1.28) |
| Hispanics | 0.98(0.78–1.21) | 0.91(0.82–1.03) | 0.98(0.74–1.31) |
| Others | 0.90(0.69–1.18) | 1.09(0.98–1.23) | 0.83(0.59–1.17) |
| Region | |||
| Large metro | Ref | Ref | Ref |
| Small metro | 1.20(1.04–1.38) | 1.03(0.96–1.10) | 1.02(0.85–1.22) |
| Micropolitan | 1.48(1.21–1.82) | 1.15(1.05–1.27) | 1.19(0.93–1.54) |
| Not metro or micro | 2.06(1.66–2.54) | 1.25(1.12–1.39) | 2.40(1.88–3.08) |
| Area-level income | |||
| Q4-highest | Ref | Ref | Ref |
| Q3 | 1.35(1.14–1.60) | 0.98(0.90–1.07) | 1.09(0.88–1.35) |
| Q2 | 1.15(0.96–1.38) | 1.02(0.93–1.11) | 1.01(0.81–1.26) |
| Q1-lowest | 1.28(1.07–1.54) | 0.98(0.90–1.07) | 1.05(0.84–1.32) |
| Insurance | |||
| Private | Ref | Ref | Ref |
| Medicaid | 0.84(0.70–1.02) | 0.91(0.80–1.03) | 1.02(0.70–1.50) |
| Medicare | 0.41(0.35–0.49) | 0.66(0.61–0.72) | 0.36(0.30–0.43) |
| Other | 2.05(1.70–2.47) | 1.73(1.55–1.92) | 2.40(1.88–3.08) |
| # Comorbiditiesa | 1.43(1.31–1.57) | 1.46(1.41–1.51) | 1.44(1.31–1.58) |
| Metastasis | |||
| Non-metastatic | Ref | Ref | Ref |
| Metastatic | 9.57(8.32–11.01) | 2.43(2.30–2.58) | 11.51(9.82–13.49) |
| Cancer surgery* | |||
| No | Ref | Ref | - |
| Yes | 0.02(0.01–0.03) | 0.43(0.40–0.45) | - |
| Length of Stay | 1.05(1.05–1.06) | 1.04(1.03–1.04) | 1.04(1.03–1.05) |
a
Comorbidities assessed based on ICD9 codes for the folowing: myocardial infarction, chronic heart failure, peripheral vascular disease, cerebrovascular disease, dementia, cardio-pulmonary disease, rheumatic disease, peptic ulcer disease, mild liver disease, hemiplegia, paraplegia, renal disease, liver disease, and HIV/AIDS
*
Cancer specific surgeries